New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 13, 2012
10:12 EDTVRA, MCHP, GLF, BBEP, RDY, YUM, TSO, MTB, FRME, AVGO, ENOC, BGS, RFMD, HBC, DRC, CRL, LLYOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Avago (AVGO) upgraded to Buy from Neutral at Goldman... BreitBurn Energy (BBEP) upgraded to Neutral from Underperform at Credit Suisse... Charles River Labs (CRL) upgraded to Outperform from Market Perform at Wells Fargo... Dresser-Rand (DRC) upgraded to Positive from Neutral at Susquehanna... First Merchants (FRME) upgraded to Outperform from Market Perform at Keefe Bruyette... GulfMark Offshore (GLF) upgraded to Outperform from Market Perform at Wells Fargo... HSBC (HBC) upgraded to Buy from Hold at Deutsche Bank... M&T Bank (MTB) upgraded to Outperform from Market Perform at Keefe Bruyette... Microchip (MCHP) upgraded to Neutral from Sell at Goldman... RF Micro Devices (RFMD) upgraded to Overweight from Equal Weight at Barclays... Tesoro (TSO) upgraded to Outperform from Neutral at Credit Suisse... Vera Bradley (VRA) upgraded to Buy from Hold at Jefferies... B&G Foods (BGS) upgraded to Outperform from Sector Perform at RBC Capital... Yum! Brands (YUM) upgraded to Buy from Neutral at Goldman... Charles River Labs (CRL) upgraded to Overweight from Neutral at JPMorgan... Eli Lilly (LLY) upgraded to Neutral from Underperform at Cowen... EnerNOC (ENOC) upgraded to Outperform from Market Perform at Raymond James... Dr. Reddy's Labs (RDY) upgraded to Outperform from Neutral at Credit Suisse.
News For AVGO;BBEP;DRC;FRME;GLF;HBC;MTB;MCHP;RFMD;TSO;VRA;BGS;YUM;LLY;ENOC;RDY;CRL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
December 8, 2014
11:44 EDTBBEPBreitBurn Energy, Legacy Reserves, Mid-Con Energy downgraded at Wells Fargo
Subscribe for More Information
11:36 EDTBBEPBreitBurn Energy downgraded to Market Perform from Outperform at Wells Fargo
Subscribe for More Information
09:13 EDTYUMYum! Brands to host analyst and investor meeting
Subscribe for More Information
08:10 EDTLLYLilly, Anthem, HealthCore form five-year research collaboration
Eli Lilly and Company (LLY), Anthem (ANTM) and HealthCore, Inc. announced that they have formed a five-year, real-world evidence research collaboration intended to improve health outcomes for patients. The companies will jointly develop and conduct research projects in health outcomes and real-world evidence in areas of mutual interest. Each party will bring distinct and valuable contributions to the collaboration, including the U.S. provider and patient environment, research capabilities, therapeutics and methods expertise, and integrated, researchable data. The collaboration allows the organizations to explore research opportunities across disease states and incorporate surveys and other information from providers and patients.
06:46 EDTYUMYum! Brands coverage resumed with a Sell at Goldman
Subscribe for More Information
December 5, 2014
10:44 EDTBBEPOptions with increasing implied volatility
Subscribe for More Information
10:40 EDTAVGOOptions with decreasing implied volatility
Subscribe for More Information
December 4, 2014
10:36 EDTBBEPOptions with increasing implied volatility
Subscribe for More Information
10:24 EDTAVGOOptions with decreasing implied volatility: AVNR ASNA ANF AVGO PVH
Subscribe for More Information
10:08 EDTTSOOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:23 EDTAVGOOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Avago (AVGO), up 7.2%... Kroger (KR), up 3.1%... Rite Aid (RAD), up 3.1%... Sears Holdings (SHLD), up 2.3%. ALSO HIGHER: Array Biopharma (ARRY), up 24% after reaching a definitive agreement with Novartis (NVS) to regain full worldwide rights to binimetinib... Hawaiian Electric (HE), up 13.5% following merger announcement with NextEra Energy (NEE)... SinoCoking Coal (SCOK), up 14.2% after beginning construction of second aboveground Syngas facility... Plug Power (PLUG), up 12.3% after announcing $20M ReliOn fuel cell contract... Mobileye (MBLY), up 3.4% after being upgraded to Buy from Hold at Deutsche Bank... CTI BioPharma (CTIC), up 3.6% following $15M payment from Teva for TRISENOX... TASER (TASR), up 3% after receiving multiple orders of AXON body cameras. DOWN AFTER EARNINGS: Barnes & Noble (BKS), down 7.6%... Express (EXPR), down 11.3%... Toronto-Dominion Bank (TD), down 1.4%... Toro Company (TTC), down 1.1%... Aeropostale (ARO), down 14.1%. ALSO LOWER: Kindred Biosciences (KIN), down 29.3% after announcing that it will discontinue its AtoKin study... UTi Worldwide (UTIW), down 13% after saying that there are no current talks with DSV A/S... Agree Realty (ADC), down 3.7% after 2.1M share Spot Secondary priced at $29.90.
08:48 EDTTSOTesoro initiated with a Buy at Tudor Pickering
Subscribe for More Information
08:19 EDTAVGOAvago price target raised to $120 from $100 at Oppenheimer
Subscribe for More Information
08:09 EDTAVGOAvago price target raised to $115 from $90 at Pacific Crest
Pacific Crest hiked its price target on Avago after the company reported better than expected Q4 results and provided stronger than expected Q1 guidance. The firm notes that the company achieved $200M in cost synergies from LSI ahead of schedule. It keeps an Outperform rating on the shares.
07:54 EDTAVGOAvago price target raised to $122 from $97 at Canaccord
Canaccord raised its price target on Avago (AVGO) to $122 from $97 following strong Q4 results, which were driven by strength in its wireless division. The firm cited Avago's Apple (AAPL) relationship, industry leading proprietary FBAR filter portfolio, and growing sales to the China LTE smartphone OEM base. Canaccord reiterated its Buy rating on Avago shares.
07:53 EDTAVGOAvago price target raised to $120 from $105 at Brean Capital
Subscribe for More Information
07:28 EDTAVGOAvago price target raised to $115 from $87 at UBS
Subscribe for More Information
07:28 EDTAVGOAvago sees Q1 non-GAAP revenue flat to up 4%
Consensus $1.51B. Sees Q1 non-GAAP gross margin 57.5% +/- 1%. Capital expenditures for FY15 are expected to be approximately $600M, of which approximately $200M is expected to occur in the first quarter. Revenue, margin and capex guidance issued last night in conjunction with Q4 report.
07:14 EDTAVGOAvago price target raised to $110 from $105 at Citigroup
Citigroup raised its price target for Avago shares to $110 saying the company is "firing on all cylinders" following its October quarter earnings report. Citi keeps a Buy rating on the stock.
06:30 EDTAVGOAvago price target raised to $115 from $100 at Deutsche Bank
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use